Study of mysterious cancer makes doubt disappear 02 Feb 2021 Mariecar Jara-Puyod, Senior Reporter The developments on science and technology (S&T) continue and hopefully, by 2023 at the earliest, considering success rates and approval by regulatory bodies, available worldwide would be an additional re-engineered therapy to the mysterious blood cancer chronic condition called Multiple Myeloma (MM). The hope, Dr. Mustaqeem Siddiqui expressed on Tuesday afternoon, when he also discussed a breakthrough already evidenced to “silence” an abnormal “gene” detected in Thalassemia and Sickle Cell Disease sufferers. This breakthrough makes them off the hook to “as many as blood transfusions and frequent hospital visits due to “certain (conditions) such as (excruciating) pain and difficulty in breathing.”